Othram has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Othram is raising up to $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Mittelman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Othram
Othram enables human identification from difficult evidence such as touch DNA, rootless hair, and decades-old bones. We specialize in unsolvable cold cases. Othram operates DNA sequencing and genomics laboratory intended to advance biometrics and human identification. The companys laboratory helps to harness the full potential of genome sequencing to deliver genomic insight operate at the intersection of molecular biology, population genetics, and bioinformatics, enabling autopsy investigators to get genomic understanding from degraded and low-input DNA samples.
To learn more about Othram, visit http://www.othram.com/
Contact:
David Mittelman, Chief Executive Officer
832-906-4247
https://www.linkedin.com/in/mittelmanlab/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.